Disease details

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00755807 (ClinicalTrials.gov)	October 2008	17/9/2008	Duloxetine for Multiple Sclerosis Pain	Duloxetine in Patients With Central Neuropathic Pain Due to Multiple Sclerosis.	Multiple Sclerosis	Drug: Duloxetine Hydrochloride (HCI);Drug: Placebo	Eli Lilly and Company	NULL	Completed	18 Years	N/A	All	239	Phase 3	United States;Belgium;Canada;Poland
2	EUCTR2008-002560-34-BE (EUCTR)	02/09/2008	29/07/2008	A Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Duloxetine HCl in Patients with Central Neuropathic Pain Due to Multiple Sclerosis - HMFR	A Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Duloxetine HCl in Patients with Central Neuropathic Pain Due to Multiple Sclerosis - HMFR	Central neuropathic pain due to Multiple sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10054095;Term: Neuropathic pain	Trade Name: Cymbalta Product Name: Duloxetine Product Code: LY248686 INN or Proposed INN: DULOXETINE	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	238		Belgium
3	NCT00457730 (ClinicalTrials.gov)	January 2007	4/4/2007	A Study to Test the Use of Duloxetine for Pain in MS	A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis	Multiple Sclerosis	Drug: Duloxetine;Drug: Placebo	Brown, Theodore R., M.D., MPH	Eli Lilly and Company	Completed	18 Years	N/A	All	38	Phase 2/Phase 3	United States